14-day Premium Trial Subscription Try For FreeTry Free
$0.0625
+0 (+0%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Friday, 3rd May 2024 BLPH stock ended at $0.0625. During the day the stock fluctuated 0% from a day low at $0.0625 to a day high of $0.0625.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Dec 13, 2021 $2.67 $2.71 $2.60 $2.62 22 921
Dec 10, 2021 $2.60 $2.75 $2.55 $2.68 33 597
Dec 09, 2021 $2.64 $2.66 $2.61 $2.61 12 628
Dec 08, 2021 $2.69 $2.81 $2.55 $2.66 49 082
Dec 07, 2021 $2.45 $2.60 $2.45 $2.57 67 883
Dec 06, 2021 $2.72 $2.72 $2.35 $2.48 77 937
Dec 03, 2021 $2.80 $2.87 $2.60 $2.65 42 625
Dec 02, 2021 $2.78 $2.91 $2.70 $2.84 21 263
Dec 01, 2021 $3.14 $3.19 $2.75 $2.82 114 520
Nov 30, 2021 $3.20 $3.20 $3.11 $3.18 39 243
Nov 29, 2021 $3.24 $3.25 $3.17 $3.17 25 962
Nov 26, 2021 $3.37 $3.37 $3.18 $3.25 28 758
Nov 24, 2021 $3.38 $3.43 $3.26 $3.37 18 972
Nov 23, 2021 $3.21 $3.39 $3.19 $3.37 44 240
Nov 22, 2021 $3.49 $3.49 $3.17 $3.29 25 787
Nov 19, 2021 $3.69 $3.72 $3.42 $3.48 51 266
Nov 18, 2021 $3.84 $3.90 $3.63 $3.73 52 455
Nov 17, 2021 $3.59 $3.82 $3.53 $3.82 59 666
Nov 16, 2021 $3.42 $3.59 $3.40 $3.59 40 786
Nov 15, 2021 $3.26 $3.40 $3.26 $3.39 45 593
Nov 12, 2021 $3.24 $3.24 $3.10 $3.14 25 339
Nov 11, 2021 $3.21 $3.23 $3.15 $3.23 20 481
Nov 10, 2021 $3.31 $3.33 $3.19 $3.20 27 936
Nov 09, 2021 $3.38 $3.38 $3.27 $3.34 32 569
Nov 08, 2021 $3.44 $3.44 $3.29 $3.39 49 309
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT